Why is SMS Pharma. falling/rising?

As of 19-Aug, SMS Pharmaceuticals Ltd is experiencing a price increase, currently at 239.55, reflecting a rise of 3.5 or 1.48%. The stock has shown a positive trend recently, gaining for the last four consecutive days and achieving a return of 4.02% over the past week. However, despite this short-term gain, the stock has underperformed over the last month with a decline of 4.90% and a significant drop of 20.36% over the past year. Notably, the stock is trading at a discount compared to its peers, and while it has generated negative returns over the year, its profits have increased by 28.4%, indicating a potential for recovery. The stock's current valuation metrics, including a fair ROCE of 11.5 and a PEG ratio of 1.3, suggest that it may be undervalued, contributing to its recent upward movement.
In the broader market context, SMS Pharmaceuticals Ltd has outperformed the Sensex by 1.61% today, which indicates a stronger performance relative to the overall market. The Sensex has shown a modest gain of 1.76% over the past week, while SMS Pharmaceuticals has significantly outpaced this benchmark. However, it is important to note that investor participation has decreased, with delivery volume falling by 49.08% against the 5-day average, which may raise concerns about the sustainability of the stock's recent gains. Overall, while the stock is currently rising, its longer-term performance remains challenged compared to the broader market trends.